Arindam Maitra
Biographic Data
| ID | 9021094 |
|---|---|
| NAME | Arindam Maitra |
| GIVEN NAMES | Arindam |
| FAMILY NAME | Maitra |
| SIGNATURE | MAITRA A |
| AFFILIATIONS | National Institute of Biomedical Genomics |
| ORCID | 0000-0002-0249-8856 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Multi-Omics for Mothers and Infants (Momi) Consortium
Background: The Multi-Omics for Mothers and Infants (MOMI) Consortium aims to define biological mechanisms associated with preterm birth, small for gestational age, preeclampsia, and stillbirth. Globally, the burden of adverse pregnancy outcomes (APOs) is highest in low- and middle-income countries (LMICs). The MOMI Consortium consists of six different LMIC sites established by The Alliance for Maternal and Newborn Health Improvement in Banglades…
“The Covid-19 pandemic in BRICS
Brazil, Russia, India, China, and South Africa (BRICS) are a group of developing countries with shared economic, healthcare, and scientific interests. These countries navigate multiple syndemics, and the COVID-19 pandemic placed severe strain on already burdened BRICS’ healthcare systems, hampering effective pandemic interventions. Genomic surveillance and molecular epidemiology remain indispensable tools for facilitating informed pandemic interv…
No prominent works on this page.
“The Covid-19 pandemic in BRICS
Brazil, Russia, India, China, and South Africa (BRICS) are a group of developing countries with shared economic, healthcare, and scientific interests. These countries navigate multiple syndemics, and the COVID-19 pandemic placed severe strain on already burdened BRICS’ healthcare systems, hampering effective pandemic interventions. Genomic surveillance and molecular epidemiology remain indispensable tools for facilitating informed pandemic interv…
Multi-Omics for Mothers and Infants (Momi) Consortium
Background: The Multi-Omics for Mothers and Infants (MOMI) Consortium aims to define biological mechanisms associated with preterm birth, small for gestational age, preeclampsia, and stillbirth. Globally, the burden of adverse pregnancy outcomes (APOs) is highest in low- and middle-income countries (LMICs). The MOMI Consortium consists of six different LMIC sites established by The Alliance for Maternal and Newborn Health Improvement in Banglades…
Adverse effect (1 work) · China (1 work) · Data collection (1 work) · Development economics (1 work) · Disease (1 work) · Economic growth (1 work) · Economics (1 work) · Environmental health (1 work) · Epidemiology (1 work) · Gestational Diabetes Research and Management (1 work)